© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Biocon to go Ahead with Syngene IPO, Listing Likely in July
Posted 19th May 2015

Biocon to go Ahead with Syngene IPO, Listing Likely in July

Biotechnology major Biocon on Wednesday filed a prospectus with market regulator Securities and Exchange Board of India (Sebi) for the Initial Public Offer (IPO) of its research arm, Syngene, through which it aims to raise around Rs 600 crore for funding research and development (R&D).

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Biocon to go Ahead with Syngene IPO, Listing Likely in July

Biocon to go Ahead with Syngene IPO, Listing Likely in July

View Biography
Amarchand & Mangaldas

Biopharmaceuticals major Biocon on Tuesday said that the unlocking of the value from its contract research subsidiary Syngene would help the company fund its research and development programmes.

Syngene has already filed the draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (SEBI), seeking approval for an initial public offering (IPO). The company is estimated to be raising around Rs 600 crore through this public issue.

“We are unlocking value from Syngene to fund our R&D programmes, which include a rich pipeline of biosimilars and novel biologics. This fund infusion will help accelerate these programmes which are at various stages of development currently,” said Kiran Mazumdar-Shaw, chairperson and managing director, Biocon.

This is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene. Biocon along with its subsidiary Biocon Research Limited (BRL), currently holds an 84.5 per cent equity stake in Syngene. The company is offering to sell up to 22 million equity shares of face value of Rs 10 each, through Syngene’s IPO.

The offer includes a reservation of two million equity shares for Biocon’s public equity shareholders, being individuals and Hindu Undivided Families (HUFs). The offer would constitute 11 per cent of the post offer paid-up equity share capital of the company.

Established in 1993, Syngene offers a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies. The company’s service offerings also support the development of biosimilar and generic molecules.

During the nine months period-ended December 31, 2014, Syngene serviced 195 clients, ranging from multinational corporations to start-ups, including seven of the top 10 global pharmaceutical companies by sales for 2014.

Syngene had reported revenues of Rs 707.7 crore for the previous financial year-ended March 31, 2014 and Rs 617.5 crore for the nine months period ended December 31, 2014. Earlier this month, the company appointed Peter Bains as its Chief Executive Officer. Bains has been a part of Syngene since January 2010 as a director and has more than two decades of experience in the pharmaceutical space.

“Syngene has a proven track record of providing quality NME discovery, development and manufacturing services. It has long-standing partnerships with three of the world’s leading global healthcare organisations, including Bristol-Myers Squibb Co. and has attracted equity participation from India Value Fund recently, which is reflective of the scale, the value and the quality of the differentiated business model of Syngene,” added Mazumdar-Shaw.

Categories: Finance


You Might Also Like
Read Full PostRead - Eye Icon
Most Dedicated Audio Technology CEO 2023 (Barcelona): Mercè Delgado
Innovation
10/07/2023Most Dedicated Audio Technology CEO 2023 (Barcelona): Mercè Delgado

In recent years, the technological industry has seen notable changes when it comes to women’s representation and opportunities. While women continue to be underrepresented in certain leadership and technical roles, there is no denying the growing recognition

Read Full PostRead - Eye Icon
Litigation Experts  on the Case
Finance
26/06/2017Litigation Experts on the Case

Beyerlein Attorneys is a Mannheim-based law-firm, highly specialised in Intellectual Property (IP), life sciences and complex litigation. As part of the Leading Advisor 2017 awards, the firm and Thorsten Beyerlein were delighted to receive the esteemed Leading

Read Full PostRead - Eye Icon
Essential Tips on Getting a Title Loan
News
06/03/2024Essential Tips on Getting a Title Loan

Are you ready to deal with an emergency if one comes up? You know something is bound to go wrong at some point, whether it’s a broken water pipe, car repair bill, or unforeseen medical expense. You don’t have the cash to cover the costs in an accou

Read Full PostRead - Eye Icon
Post Haste!
Leadership
06/05/2022Post Haste!

The team at MailAmericas are a vital link for those in Latin America and have expanded across borders. This growth has seen them named Best Cross-Border Logistics Solutions Provider 2021 – Americas in Acquisition International’s Global Excellence Awards.

Read Full PostRead - Eye Icon
CEO’s Must Be Set Up for Success When Eyeing up M&A Exits
News
04/09/2024CEO’s Must Be Set Up for Success When Eyeing up M&A Exits

Companies’ sale memorandums are often compendiums that fail to tell a compelling story, and while compiling key information has value, it does not sell a business for the maximum price, says Victor Basta, CEO and Founder of DAI Magister.

Read Full PostRead - Eye Icon
Minimum Wage Workers Will Be Hit by Chancellor’s Cuts, Says TUC
Strategy
17/03/2015Minimum Wage Workers Will Be Hit by Chancellor’s Cuts, Says TUC

TUC General Secretary spoke about new minimum wage rates.

Read Full PostRead - Eye Icon
SASE – The Security Fabric of The Future
News
05/02/2024SASE – The Security Fabric of The Future

The rise of cloud computing, the pervasiveness of mobile devices, and the widespread adoption of remote work have rendered traditional network security architectures obsolete and ineffective. To address these evolving threats and safeguard their valuable asset

Read Full PostRead - Eye Icon
Going Above and Beyond for Clients
Leadership
07/05/2019Going Above and Beyond for Clients

The Law Offices of Anthony Carbone was founded by Jersey City attorney Anthony Carbone. Following his success as being selected as 2018’s Best Personal Injury Law Firm - New Jersey by Acquisition Intl., we profiled the firm and caught up with Anthony who pro

Read Full PostRead - Eye Icon
Banking Industry Should Learn from Telecoms Sector in Approach to Product Sales
Finance
12/12/2016Banking Industry Should Learn from Telecoms Sector in Approach to Product Sales

Specialist management consultancy Baringa Partners responds to the news that HSBC has closed 200 branches this year.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow